Design and Validation of a Questionnaire to Measure Treatment Satisfaction in Patients With Moderate-to-Severe Psoriasis: the NEODERMA Study

Ribera, Miquel; Daudén, E.; Puig, Lluís; Briones, Vicente García-Patos; Herranz, J.M.; Bordas, X.; Vanaclocha, F.

doi:10.1016/s1578-2190(11)70750-8

Cited by 9 publications

(16 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…One study 28 was an intervention study; only preintervention findings were extracted regarding the adherence rate. Three studies 28–30 examined adherence rates, 19 studies examined adherence rates and determinants of adherence, 15,24–27,31–47 and five studies 15,24,25,48–51 examined adherence as a determinant of clinical response, as assessed by disease severity. One study 33 examined hospitalizations, emergency department visits and total healthcare costs as outcomes of adherence.…”

Section: Resultsmentioning

confidence: 99%

Adherence to medication in patients with psoriasis: a systematic literature review

Thorneloe

Bundy

Griffiths

et al. 2012

British Journal of Dermatology

147

144

View full text Add to dashboard Cite

Psoriasis is associated with considerable physical and psychological morbidity. Optimal use of psoriasis treatments can limit the physical manifestations of psoriasis and help improve quality of life, but nonadherence is common. Smoking, obesity and excessive alcohol consumption are prevalent in this population. A systematic review of adherence to medication and recommendations for lifestyle change in psoriasis was undertaken, with a critical appraisal of the quality of the selected studies. Electronic searches from inception to March 2012 (PubMed, Web of Science and Embase) were conducted. Twenty-nine studies were included; however, none examined adherence to advice about lifestyle change. Studies using a dichotomous classification of adherence tended to report suboptimal adherence, with 21·6-66·6% of patients classed as adherent. No consistent pattern of results emerged for sociodemographical, disease and lifestyle factors as determinants of adherence. However, some treatment factors were associated with adherence. While mixed findings were reported for quality of life as a determinant of adherence, psychological factors (psychological distress and patient satisfaction with care and therapy) were associated with adherence. Only tentative conclusions can be made for determinants of adherence because the methodological quality of many of the included studies limits conclusions. There is a need for improved quality of research and reporting in this area, and this review provides a platform from which future research within this area should progress, along with suggested research recommendations.

show abstract

Section: Resultsmentioning

confidence: 99%

Adherence to medication in patients with psoriasis: a systematic literature review

Thorneloe

Bundy

Griffiths

et al. 2012

British Journal of Dermatology

147

144

View full text Add to dashboard Cite

show abstract

“…Spanish Satisfaction With Treatment of Psoriasis Questionnaire (SSWTPQ) SSWTPQ was comprehensive and relevant [40], resulting in a "positive" content validity rating. Due to "fair" COSMIN methodology, this rating had a "limited" level of evidence.…”

Section: Psoriasis-specific Measuresmentioning

confidence: 99%

“…For structural validity, factors explained over 50% of the variance [40], resulting in a "positive" rating. Due to the property's "fair" COSMIN methodology, this rating had a "limited" level of evidence.…”

Section: Psoriasis-specific Measuresmentioning

confidence: 99%

See 1 more Smart Citation

Are Your Patients Satisfied A Systematic Review of Treatment Satisfaction Measures in Psoriasis

et al. 2018

View full text Add to dashboard Cite

Treatment satisfaction is paramount to the field of dermatology. Treatment dissatisfaction directly impacts patient outcomes and health care delivery. A critical need exists for standardized, validated treatment satisfaction measures in dermatology. Comprehensive evaluation of the performance of treatment satisfaction instruments used in psoriasis is lacking. We sought to critically appraise the literature on measurement properties of treatment satisfaction instruments used in psoriasis. We performed a systematic review to identify treatment satisfaction instruments used in psoriasis and corresponding studies on their measurement properties. We followed the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) methodology to inform a best evidence synthesis. Eleven instruments were identified. Six achieved positive content validity ratings, 2 achieved positive reliability and structural validity ratings, and 1 achieved a positive internal consistency rating. The REFlective evaLuation of psoriasis Efficacy of Treatment and Severity (REFLETS) and the Spanish Satisfaction With Treatment of Psoriasis Questionnaire (SSWTPQ) had the highest overall performance. Measurement property data for treatment satisfaction instruments were found to be insufficient in identifying a single best treatment satisfaction instrument for psoriasis. Additional studies are required to better characterize the measurement properties of treatment satisfaction measures and allow for standardized assessments across psoriasis clinical trials and clinical practice.

show abstract

“…In one study, more than a third of patients who did not achieve a PASI50 response showed a high level of satisfaction with treatment, while 15% of those achieving PASI75 were not satisfied (33). Several methods are available to evaluate patients' satisfaction with treatment, including the Satisfaction with Treatment of Psoriasis Questionnaire (34). Treatment satisfaction is higher with biologic therapy than with topical or systemic treatments (35).…”

Section: Patient/clinician Expectationsmentioning

confidence: 99%

Recommendations for managing a suboptimal response to biologics for moderate-to-severe psoriasis: A Belgian perspective

Brassinne

Ghislain

Lambert³

et al. 2015

Journal of Dermatological Treatment

View full text Add to dashboard Cite

Over the past decade, biologics have become the gold standard in the treatment of moderate-to-severe psoriasis for patients who have failed or who have contraindications to traditional systemic treatments. However, although practical recommendations on how to treat a suboptimal response to biologics exist in other chronic inflammatory diseases, they are only just beginning to emerge for psoriasis. This article aims to formulate recommendations in the case of a suboptimal response of psoriasis to biologics in the Belgian setting. A Belgian taskforce of psoriasis experts was convened to review the results of a literature search and formulate recommendations based on the available evidence and provide expert opinion to address gaps in the evidence. The taskforce has proposed a treatment algorithm for patients with a primary non-response or a secondary loss of response to help address an unmet need. Expert recommendations have been developed to address treatment strategies in case of a primary or secondary suboptimal response to biologics in the treatment of moderate-to-severe psoriasis in Belgium.

show abstract

Design and Validation of a Questionnaire to Measure Treatment Satisfaction in Patients With Moderate-to-Severe Psoriasis: the NEODERMA Study

Cited by 9 publications

References 24 publications

Adherence to medication in patients with psoriasis: a systematic literature review

Adherence to medication in patients with psoriasis: a systematic literature review

Are Your Patients Satisfied A Systematic Review of Treatment Satisfaction Measures in Psoriasis

Recommendations for managing a suboptimal response to biologics for moderate-to-severe psoriasis: A Belgian perspective

Contact Info

Product

Resources

About